CYCN (CYCN)
Cyclerion Therapeutics, Inc.
NASDAQ:CYCNHealthcare · Biotechnology
-20.94%$3.36
Mkt Cap-
Float465K
O/S-
Inst Own-
SI0.6%
Dilution
MCap-
Float465K
O/S-
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$2.07M
Net Income-$3.53M
Total Assets$9.98M
Free Cash Flow-$3.31M
Debt & Equity
Equity 100%
Total Debt$0
Total Equity$9.09M
Shares Outstanding
Short Interest
Split History2 splits · 2 reverse
2-year cumulative
1:7
Nasdaq bars a compliance period at 1:250
- 1:7Reverse splitSep 9, 20267 shares → 1
- 1:20Reverse splitMay 16, 202320 shares → 1
Balance Sheet Details
Assets$9.98M
Liabilities$900K
Accounts Receivable$1M
Accounts Payable$508K
Inventory$0
PP&E (Net)$0
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
| Revenue | $2.07M | $2M | $0 | $297K | $3.32M | $2.3M | $4.51M | $0 | $0 | $0 |
| YoY Growth | 3.7% | - | - | -91.1% | 44.6% | -49.1% | - | - | - | - |
| Cost of Revenue | $0 | $0 | $1.31M | $5.58M | $0 | $56.41M | $95.14M | $1.53M | $1.75M | $2.17M |
| Gross Profit | $2.07M | $2M | -$1.31M | -$5.28M | $3.32M | -$54.12M | -$90.63M | -$1.53M | -$1.75M | -$2.17M |
| Gross Margin | 100.0% | 100.0% | - | -1778.5% | 100.0% | -2357.1% | -2010.9% | - | - | - |
| Research and Development | $959K | $286K | $1.51M | $5.98M | $37.64M | $56.41M | $95.14M | $87.72M | $78.8M | $50.9M |
| Selling, General, and Administrative | $6.09M | $5.34M | $8.33M | $13.26M | $20.62M | $28.82M | $34.4M | $27.54M | $15.12M | $10.48M |
| Other | $0 | $0 | $1.79M | -$5.98M | $259K | -$58.08M | -$95.14M | $0 | $0 | $0 |
| Total Operating Expenses | $7.05M | $5.63M | $11.64M | $13.26M | $58.52M | $27.15M | $34.4M | $115.25M | $93.92M | $61.38M |
| Operating Income (EBIT) | -$4.97M | -$3.63M | -$12.95M | -$18.54M | -$55.2M | -$81.27M | -$125.04M | -$115.25M | -$93.92M | -$63.55M |
| Operating Margin | -239.8% | -181.4% | - | -6242.4% | -1662.5% | -3539.4% | -2774.3% | - | - | - |
| Interest Expense | $0 | $0 | $0 | $0 | $16K | $0 | $0 | $0 | $0 | $0 |
| Interest Income | $128K | $208K | $358K | $294K | $0 | $588K | $2.03M | $0 | $0 | $0 |
| Other Income (Expense) | $1.45M | $571K | $358K | $294K | $3.55M | $3.46M | $2.03M | $0 | $0 | $0 |
| Income Before Tax (EBT) | -$3.53M | -$3.06M | -$12.59M | -$18.25M | -$51.65M | -$77.8M | -$123.01M | -$115.25M | -$93.92M | -$63.55M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$3.53M | -$3.06M | -$5.26M | -$44.08M | -$51.65M | -$77.8M | -$123.01M | -$115.25M | -$93.92M | -$63.55M |
| Net Income Margin | -170.1% | -152.8% | - | -14841.1% | -1555.6% | -3388.6% | -2729.3% | - | - | - |
| Supplementary Data | ||||||||||
| EPS | -7.63 | -8.47 | -62.93 | -141.05 | -184.80 | -334.60 | -618.59 | -590.94 | -481.60 | -324.73 |
| Diluted EPS | -7.63 | -8.47 | -62.93 | -141.05 | -184.80 | -334.60 | -618.59 | -590.94 | -481.60 | -324.73 |
| Weighted Average OS | 460,714 | 359,714 | 334,000 | 310,429 | 279,600 | 217,164 | 195,571 | 195,032 | 195,029 | 195,726 |
| EBITDA | -$3.53M | -$3.06M | -$9.58M | -$18.18M | -$53.84M | -$80.64M | -$122.34M | -$113.72M | -$92.18M | -$61.38M |
| EBITDA Margin | -170.1% | -152.8% | - | -6121.5% | -1621.7% | -3512.1% | -2714.4% | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
| Assets | |||||||||
| Current Assets | |||||||||
| Cash and Cash Equivalents | $3.24M | $3.23M | $7.57M | $13.38M | $53.96M | $54.4M | $97.59M | $0 | $0 |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $3.24M | $3.23M | $7.57M | $13.38M | $53.96M | $54.4M | $97.59M | $0 | $0 |
| Accounts Receivable | $1M | $556K | $0 | $96K | $100K | $127K | $1.47M | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $928K | $0 | $0 | $0 | $0 |
| Other Current Assets | $11K | $16K | $11K | $537K | $468K | $1.56M | $162K | $12K | $8K |
| Total Current Assets | $4.63M | $4.22M | $8.02M | $14.82M | $55.46M | $58.5M | $101.2M | $879K | $1.26M |
| Long-Term Assets | |||||||||
| Property, Plant & Equipment Net | $0 | $0 | $0 | $1.22M | $1.47M | $50.27M | $79.75M | $6.5M | $4.13M |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $5.35M | $5.35M | $5.35M | $0 | $0 | $0 | $4.99M | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $0 | $0 | $2.04M | $2.41M | $6.61M | $540K | $25K | $80K |
| Total Long-Term Assets | $5.35M | $5.35M | $5.35M | $3.26M | $3.87M | $56.88M | $85.28M | $6.52M | $4.21M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $9.98M | $9.57M | $13.37M | $18.08M | $59.33M | $115.38M | $186.48M | $7.4M | $5.47M |
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts Payable | $508K | $390K | $1.2M | $2.97M | $1.83M | $1.15M | $3.31M | $2.78M | $1.8M |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $3.51M | $3.42M | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $51K | $63K | $102K | $68K | $7.28M | $176K | $5.05M | $7.27M | $5.62M |
| Total Current Liabilities | $900K | $725K | $2.09M | $7.63M | $11.09M | $16.95M | $18.25M | $17.85M | $14.04M |
| Long-Term Liabilities | |||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 | $38.93M | $70.5M | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $900K | $725K | $2.09M | $7.63M | $11.09M | $55.88M | $88.75M | $17.85M | $14.04M |
| Stockholders' Equity | |||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Retained Earnings | -$271.02M | -$267.49M | -$264.42M | -$259.15M | -$215.08M | -$163.43M | -$85.63M | $0 | $0 |
| Comprehensive Income & Other | $0 | $0 | -$12K | -$20K | -$23K | -$27K | -$20K | -$15.49M | -$15.87M |
| Other Stockholders' Equity | $280.11M | $276.34M | $275.7M | $269.61M | $263.32M | $222.92M | $183.36M | -$10.45M | -$8.57M |
| Total Equity | $9.09M | $8.85M | $11.29M | $10.45M | $48.25M | $59.49M | $97.73M | -$10.45M | -$8.57M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $9.98M | $9.57M | $13.37M | $18.08M | $59.33M | $115.38M | $186.48M | $7.4M | $5.47M |
| Supplementary Data | |||||||||
| Total Debt | $0 | $0 | $0 | $0 | $0 | $45.73M | $73.92M | $0 | $0 |
| Net Debt | -$3.24M | -$3.23M | -$7.57M | -$13.38M | -$53.96M | -$8.66M | -$23.68M | $0 | $0 |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
| Operating Activities | ||||||||||
| Net Income | -$3.53M | -$3.06M | -$12.59M | -$18.25M | -$51.65M | -$77.8M | -$123.01M | -$115.25M | -$93.92M | -$63.55M |
| Depreciation & Amortization | $0 | $0 | $65K | $65K | $472K | $2.3M | $2.7M | $1.53M | $1.75M | $2.17M |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $441K | $625K | $0 | $0 | $9.61M | $14.99M | $19.63M | $12.43M | $9.49M | $0 |
| Changes in Working Capital: | ||||||||||
| Accounts Receivable | -$444K | -$556K | $96K | $4K | $27K | $1.35M | -$1.47M | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | -$3.18M | $0 | $0 | $0 |
| Accounts Payable | $118K | -$445K | -$1.77M | $1.14M | $393K | -$1.1M | -$250K | $979K | $392K | $508K |
| Other Working Capital | $99K | -$537K | -$2.92M | -$4M | $988K | -$7.84M | $2.61M | $2.81M | $1.07M | $3.82M |
| Total Working Capital Change | -$227K | -$1.54M | -$4.6M | -$2.85M | $1.41M | -$7.59M | -$2.29M | $3.79M | $1.47M | $4.33M |
| Other Non-Cash Items | $0 | -$363K | -$4.12M | -$19.58M | $3.64M | -$4.38M | $751K | $14.51M | $12.59M | $11.02M |
| Net Cash from Operating | -$3.31M | -$4.33M | -$21.25M | -$40.61M | -$36.52M | -$72.49M | -$102.22M | -$97.5M | -$81.22M | -$49.87M |
| Investing Activities | ||||||||||
| Capital Expenditures | $0 | $0 | $0 | $0 | -$7K | -$1.52M | -$6.89M | -$3.44M | -$1.4M | -$1.45M |
| Acquisitions | $0 | $0 | $10.4M | $0 | $0 | $0 | $173K | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | $1.46M | $1.54M | $173K | $0 | $0 | $0 |
| Net Cash from Investing | $0 | $0 | $10.4M | $0 | $1.46M | $18K | -$6.71M | -$3.44M | -$1.4M | -$1.45M |
| Financing Activities | ||||||||||
| Debt Repaid | - | - | - | - | - | - | - | - | - | - |
| Common Stock Issuance | $1.38M | $0 | $5.02M | $29K | $30.5M | $24.25M | $175M | $0 | $0 | $0 |
| Common Stock Repurchases | -$130K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $2.08M | $0 | $0 | $0 | $282K | $331K | $36.57M | $100.94M | $82.62M | $51.32M |
| Net Cash from Financing | $3.32M | $0 | $5.02M | $29K | $30.79M | $28.09M | $211.57M | $100.94M | $82.62M | $51.32M |
| Forex Effect | $0 | -$6K | $8K | $3K | $4K | -$7K | -$20K | $0 | $0 | $0 |
| Net Change in Cash | $8K | -$4.34M | -$5.81M | -$40.58M | -$4.27M | -$44.39M | $102.62M | $0 | $0 | $0 |
| Supplementary Data | ||||||||||
| Operating Cash Flow | -$3.31M | -$4.33M | -$21.25M | -$40.61M | -$36.52M | -$72.49M | -$102.22M | -$97.5M | -$81.22M | -$49.87M |
| Capital Expenditure | $0 | $0 | $0 | $0 | -$7K | -$1.52M | -$6.89M | -$3.44M | -$1.4M | -$1.45M |
| Free Cash Flow | -$3.31M | -$4.33M | -$21.25M | -$40.61M | -$36.52M | -$74.01M | -$109.1M | -$100.94M | -$82.62M | -$51.32M |
| Cash at Beginning | $3.23M | $7.57M | $13.38M | $53.96M | $58.23M | $102.62M | $0 | $0 | $0 | $0 |
| Cash at End | $3.24M | $3.23M | $7.57M | $13.38M | $53.96M | $58.23M | $102.62M | $0 | $0 | $0 |